Quality Assurance of Invasive Measures for Treatment of Parkinson Patients in Clinical Routine in Germany

Quality Assurance of Invasive Measures for Treatment of Parkinson Patients in Clinical Routine in Germany - QualiPa – THS

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00011709

Enrollment

1600

Registered

2017-07-27

Start date

2016-11-11

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

OPS 5-014.9 OPS 5-028.9 G20

Interventions

Group 1: Detection of the treatment quality in a questionnaire of Parkinsonpatients, which are adjusted stationary with THS.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Idiopathic Parkinson's syndrome (ICD-10 code: G20.-), THS intervention: Stereotactic initial implantation of intracerebral microelectrodes (OPS: 5-014.9-) and neurostimulators (OPS: 5-028.9-)

Exclusion criteria

Exclusion criteria: age < 18 yaers, no idopatic Parkinsonsyndrom, preexisting deep brain stimulation

Design outcomes

Primary

Measure	Time frame
Assessment of the treatment quality of Parkinsonian patients who are stationed with THS. The purpose of the study / register is the recording and presentation of the treatment quality of deep brain stimulation in patients with Parkinson's disease	—

Secondary

Measure	Time frame
not specified	—

Countries

Germany

Contacts

Public ContactKirsten Haas

Institut für Klinische Epidemiologie und Biometrie (IKE-B) der Universität Würzburg

Kirsten.Haas(at)uni-wuerzburg.de+49 (0)931 / 201 47311

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026